Literature DB >> 34018006

Rapidly progressive idiopathic arthritis of the hip: incidence and risk factors in a controlled cohort study of 1471 patients after intra-articular corticosteroid injection.

Robert D Boutin1, Jason Pai1, John P Meehan2, Joel S Newman3, Lawrence Yao4.   

Abstract

OBJECTIVE: Rapidly progressive idiopathic arthritis of the hip (RPIA) is defined by progressive joint space narrowing of > 2 mm or > 50% within 1 year. Our aims were to assess (a) the occurrence of RPIA after intra-articular steroid injection, and (b) possible risk factors for RPIA including: patient age, BMI, joint space narrowing, anesthetic and steroid selections, bone mineral density, and pain reduction after injection.
MATERIALS AND METHODS: A retrospective search of our imaging database identified 1471 patients who had undergone fluoroscopically guided hip injection of triamcinolone acetonide (Kenalog) and anesthetic within a 10-year period. Patient data, including hip DXA results and patient-reported pain scores, were recorded. Pre-injection and follow-up radiographs were assessed for joint space narrowing, femoral head deformity, and markers of osteoarthritis. Osteoarthritis was graded by Croft score. Associations between patient characteristics and outcome variables were analyzed.
RESULTS: One hundred six of 1471 injected subjects (7.2%) met the criteria for RPIA. A control group of 161 subjects was randomly selected from subjects who underwent hip injections without developing RPIA. Compared to controls, patients with RPIA were older, had narrower hip joint spaces, and higher Croft scores before injection (p < 0.05). Patients who developed RPIA did not differ from controls in sex, BMI, hip DXA T-score, anesthetic and steroid injectates, or pain improvement after injection.
CONCLUSION: We found that approximately 7% of patients undergoing steroid hip injection developed RPIA. More advanced patient age, greater joint space narrowing, and more severe osteoarthritis are risk factors for the development of RPIA after intra-articular steroid injection.
© 2021. ISS.

Entities:  

Keywords:  Arthritis; Corticosteroid; Hip; Intra-articular injection; Outcomes; Total hip arthroplasty

Mesh:

Substances:

Year:  2021        PMID: 34018006     DOI: 10.1007/s00256-021-03815-7

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  1 in total

1.  Bone mineral density in patients with rapidly destructive or common hip osteoarthritis.

Authors:  P Richette; E Vicaut; M-C de Vernejoul; P Orcel; T Bardin
Journal:  Clin Exp Rheumatol       Date:  2009 Mar-Apr       Impact factor: 4.473

  1 in total
  2 in total

1.  Arthroscopy Association of Canada Position Statement on Intra-articular Injections for Hip Osteoarthritis.

Authors:  Ryan M Degen; Laurie A Hiemstra; Joel Lobo; Jarrett M Woodmass; Mark Sommerfeldt; Moin Khan; Sasha Carsen; Thierry Pauyo; Jas Chahal; Nathan Urquhart; John Grant; Alexis Rousseau-Saine; Marie-Eve Lebel; Brendan Sheehan; Emilie Sandman; Allison Tucker; Michaela Kopka; Ivan Wong
Journal:  Orthop J Sports Med       Date:  2022-02-07

Review 2.  Fluoroscopic-guided procedures of the lower extremity.

Authors:  Gunjan Malhotra; Barry G Hansford; Cindy Felcher; Kristie A Wuerfel; Corrie M Yablon
Journal:  Skeletal Radiol       Date:  2022-08-05       Impact factor: 2.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.